Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Targeting One
company
About
Targeting One is an in-vitro diagnostic product developer.
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥150M
- Founded date
- Jan 1, 2015
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥150M
Targeting One has raised a total of
¥150M
in funding over 2 rounds. Their latest funding was raised on
Jan 7, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 7, 2021 | Series B | ¥150M | 3 |
Lilly Asia Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
Targeting One is funded by 3 investors.
Lilly Asia Ventures
and Qingdao Yufeng
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Lilly Asia Ventures
|
Yes | Series B |
|
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
